FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study

BACKGROUND: Reduced (18)F-fluorodeoxyglucose-positron emission tomography (FDG-PET) brain metabolism was recognized as a biomarker of neurodegeneration in the recently proposed ATN framework for Alzheimer’s disease (AD) biological definition. However, accumulating evidence suggested it is an indepen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Ya-Nan, Xu, Wei, Li, Jie-Qiong, Guo, Yu, Cui, Mei, Chen, Ke-Liang, Huang, Yu-Yuan, Dong, Qiang, Tan, Lan, Yu, Jin-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599313/
https://www.ncbi.nlm.nih.gov/pubmed/31253185
http://dx.doi.org/10.1186/s13195-019-0512-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599313/
https://www.ncbi.nlm.nih.gov/pubmed/31253185
http://dx.doi.org/10.1186/s13195-019-0512-1

Ejemplares similares